LAZARD ASSET MANAGEMENT LLC - MERRIMACK PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
LAZARD ASSET MANAGEMENT LLC ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2016$5,000
-99.3%
930
-98.9%
0.00%
-100.0%
Q1 2016$705,000
+3257.1%
84,300
+2937.8%
0.00%
Q4 2015$21,000
-75.3%
2,775
-59.9%
0.00%
Q2 2015$85,0006,9280.00%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 5,000,000$20,400,0004.19%
Consonance Capital Management LP 9,067,998$36,997,0004.06%
Lagoda Investment Management, L.P. 1,522,529$6,212,0002.13%
INDUS CAPITAL PARTNERS, LLC 1,050,000$4,284,0000.56%
WESTFIELD CAPITAL MANAGEMENT CO LP 9,072,877$37,017,0000.32%
GARRISON BRADFORD & ASSOCIATES INC 77,700$317,0000.29%
Cannell & Co. 1,572,978$6,418,0000.23%
Virtus ETF Advisers LLC 179,625$733,0000.22%
LeJeune Puetz Investment Counsel LLC 3,976$161,0000.12%
STONERIDGE INVESTMENT PARTNERS LLC 221,838$905,0000.12%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders